论文部分内容阅读
1991年4月～1992年3月我科先后随机选择应用华明阿霉素单用或为主联合用药治疗恶性肿瘤,可评价病例22例,其近期疗效和毒副作用报告如下。1 临床资料1.1 一般资料22例中晚期恶性肿瘤患者,入院后均经临床、红外、X线、生化、B超、CT、细胞、病理等5～8项联合方法检查确诊。有可测量的原发病灶或有明显的转移病灶,癌性胸腹水,消化道梗阻等并发症;已失去手术时机或术后再发病例,未接受过放化疗或虽化疗和放疗,但入院后各病灶已呈恶化趋势者。治疗前经Kamofsky生存质量评分,40分～50分者5例,60～70分者14例,70分
From April 1991 to March 1992, our department randomly selected Huaming doxorubicin alone or with a combination of drugs for the treatment of malignant tumors, 22 cases can be evaluated, its short-term efficacy and side effects are reported below. 1 Clinical data 1.1 General information 22 patients with advanced malignant tumors, after admission were clinical, infrared, X-ray, biochemical, B-ultrasound, CT, cells, pathology and other 5 to 8 joint methods of diagnosis confirmed. There are measurable primary or metastatic lesions, cancerous pleural effusion, digestive tract complications, etc.; lost surgical timing or postoperative recurrence; have not received chemoradiation or chemotherapy and radiotherapy but have been admitted to hospital After the lesions have been showing a trend of deterioration. Kamofsky quality of life score before treatment, 5 cases from 40 to 50 points, and 14 cases from 60 to 70 points, 70 points